Speech-Language Pathologists in Urbanna, VA Accepting Medicare

4 Speech-Language Pathologists found. Showing 1 - 4

Ms. Elizabeth Martin Harding, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5372b Old Virginia Street, Urbanna, VA 23175 Phone: 804-758-5250    Fax: 804-758-5183

Donna Young Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5372b Old Virginia St, Urbanna, VA 23175 Phone: 804-758-5250

Mrs. Deborah Hare Whiteway, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5372 B Old Virginia Street, Urbanna, VA 23175 Phone: 804-758-5250    Fax: 804-758-5183

Heather Toler, SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5372 Old Virginia St, Urbanna, VA 23175 Phone: 804-758-5250

News Archive

BU wins $2.75M grant from NIDCD to test and refine prototype Visually Guided Hearing Aid

Boston University (BU) College of Health & Rehabilitation Sciences: Sargent College was recently awarded a five-year, $2.75M grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) to test and refine a prototype Visually Guided Hearing Aid (VGHA).

Americans' confidence in health care system lower than other industrialized counties, study finds

"Despite having the most expensive healthcare system in the industrialized world, Americans tend to have the least confidence that their system will provide them the most-effective care compared to residents of 10 other industrialized nations, a Commonwealth Fund survey has found. A survey of nearly 20,000 people in the U.S. and 10 other industrialized nations has found that U.S. consumers reported the highest level of confusing complexity of their health insurance plans, and the highest level of concern that they would not be able to afford their healthcare coverage" (Carlson, 11/18).

Non-invasive trigeminal nerve stimulation shows promise for drug-resistant epilepsy

Medications are the mainstay of treatment for epilepsy, but for a considerable number of patients — estimated to be as many as 1 million in the U.S. — drugs don't work. These patients suffer from a type of epilepsy known as refractory or drug-resistant epilepsy, in which drugs can't control their seizures.

Varying immune system responses can predict severe COVID-19 outcomes

The differing immune system responses of patients with COVID-19 can help predict who will experience moderate and severe consequences of disease, according to a new study by Yale researchers published July 27 in the journal Nature.

New report sets out plans to improve cure rate, quality of life for childhood cancer survivors in Europe

Each year in Europe, 6,000 young people die from cancer, and two-thirds of those who survive suffer from treatment-related side effects. Although there has been considerable progress in the treatment of childhood cancers over the past few decades, and cancer in childhood is rare, these are major problems that need to be overcome, says a report from SIOPE, the European Society for Paediatric Oncology, launched at the 2015 European Cancer Congress today.

Read more Medical News

› Verified 5 days ago